however, found no “increase in the risk of clinically definite multiple sclerosis or of multiple sclerosis according to the McDonald criteria among patients who were positive for anti-MOG antibodies, anti-MBP antibodies, or both” (Kuhle et al. 2007b). This evidence concerns the gene MOG and multiple sclerosis.